| 000 | 01762 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516071442.0 | ||
| 264 | 0 | _c20120606 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkr517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoler-Palacín, Pere | |
| 245 | 0 | 0 |
_aVoriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cMar 2012 |
||
| 300 |
_a700-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycoses _xdrug therapy |
| 650 | 0 | 4 |
_aPlasma _xchemistry |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aFrick, Marie Antoinette | |
| 700 | 1 | _aMartín-Nalda, Andrea | |
| 700 | 1 | _aLanaspa, Miguel | |
| 700 | 1 | _aPou, Leonor | |
| 700 | 1 | _aRoselló, Eva | |
| 700 | 1 | _ade Heredia, Cristina Diaz | |
| 700 | 1 | _aFigueras, Concepció | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 67 _gno. 3 _gp. 700-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkr517 _zAvailable from publisher's website |
| 999 |
_c21411408 _d21411408 |
||